Longterm acid suppressant use in general practices in the region of Amsterdam;Chronisch gebruik van maagzuursecretieremmende medicatie in de huisartsenpraktijk in de regio Amsterdam

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 8, 1999, Pages 410-413

  Hurenkamp, G J B ^a   Grundmeijer, H G L M ^a   Bindels, P J E ^a   Tytgat, G N J ^a   Der Van Hulst, R W M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT;

ARTICLE; CLINICAL PRACTICE; DRUG CHOICE; DRUG EFFECT; GASTRITIS; HUMAN; LONG TERM CARE; PRESCRIPTION; STOMACH ACID SECRETION;

AGED; ANTI-ULCER AGENTS; CHRONIC DISEASE; DRUG UTILIZATION REVIEW; DYSPEPSIA; FAMILY PRACTICE; FEMALE; GASTRITIS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES;

EID: 0033585935     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lamberts H, Brouwer HJ, Mohrs J. Reason for encounter-, episode- and process-orientated standard output from Transition project. Department of general practice/family medicine. Amsterdam: Universiteit van Amsterdam: 1991.
2. Numans ME, Wit NJ de, Geerdes RHM, Jager AJ de, Muris JWM, Postema PhJ, et al. NHG-standaard Maagklachten. Huisarts Wet 1993;36:375-9.
3. Omzet top 10 geneesmiddelen 1994. Data en feiten selectic. Den Haag: Stichting Farmaceutische Kengetallen; 1995.
4. Centrale Medisch Pharmaceutische Commissie van de Ziekenfondsraad. In: Kuy A van der, redacteur. Farmacotherapeutisch kompas 1995. Amstelveen: Ziekenfondsraad: 1995.
5. Numans ME, Wit NJ de, Geerdes RHM, Muris JWM, Starmans R, Postema PhJ, et al. NHG-standaard Maagklachten, Huisarts Wet 1996;39:565-77.
6. Hulst RWM van der, Rauws EAJ, Köycü B, Keller JJ, Bruno MJ, Tijssen JG, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997;113:1082-6.
7. Labenz J, Malfertheiner P, Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut 1997;41:277-80.
8. Labenz J, Tillenburg B, Peitz U, Idström JP, Verdu EF, Stolte M. et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996:110: 725-32.
9. Talley NJ. A critique of therapeutic trials in Helicobacter pyloripositive functional dyspepsia. Gastroenterology 1994;106:1174-83.
10. Veldhuyzen van Zanten SJO, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996;91:660-73.